BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 14053296)

  • 1. PRODUCTION OF NEUTRALIZING ANTIBODY BY MICE INJECTED WITH ACTINOPHAGE.
    BRADLEY SG; WATSON DW
    J Immunol; 1963 May; 90():782-7. PubMed ID: 14053296
    [No Abstract]   [Full Text] [Related]  

  • 2. STUDIES ON THE QUALITY OF NEUTRALIZING BACTERIOPHAGE ANTIBODIES PRODUCED BY SINGLE CELLS. I. EVIDENCE INDICATING THAT DIFFERENT CELLS PRODUCE DIFFERENT KINDS OF ANTIBODY AGAINST THE TAIL OF T6.
    MAEKELAE O
    Immunology; 1964 Jan; 7(1):9-16. PubMed ID: 14113082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NEUTRALIZATION OF BACTERIOPHAGE PHI-X174 BY SPECIFIC ANTISERUM.
    BOWMAN BU; PATNODE RA
    J Immunol; 1964 Apr; 92():507-14. PubMed ID: 14139020
    [No Abstract]   [Full Text] [Related]  

  • 4. MORPHOLOGY OF ACTINOPHAGE PHI-17.
    BACQ CM
    J Gen Microbiol; 1963 Jul; 32():131-3. PubMed ID: 14045514
    [No Abstract]   [Full Text] [Related]  

  • 5. [THE BIOLOGICAL EFFECT OF ULTRAVIOLET RAYS ON ACTINOPHAGE].
    MKRTUMIAN NM; ALIKHANIAN SI
    Mikrobiologiia; 1964; 33():73-8. PubMed ID: 14150173
    [No Abstract]   [Full Text] [Related]  

  • 6. [USE OF ACTINOPHAGE IN THE INDUCTION OF A PHAGE-RESISTANT STRAIN OF ERYTHROMYCIN PRODUCER].
    ILINA Ts; ZHDANOV VG
    Mikrobiologiia; 1964; 33():516-21. PubMed ID: 14237050
    [No Abstract]   [Full Text] [Related]  

  • 7. [STUDIES ON HOST DEFENSES AGAINST CANCER. 1. ON THE BACTERIOPHAGE NEUTRALIZING ACTIVITY OF SERUMS].
    SEKIGUCHI M
    Arerugi; 1963; 12():348-57. PubMed ID: 14095328
    [No Abstract]   [Full Text] [Related]  

  • 8. [CYTOLOGICAL STUDY ON THE DEVELOPMENT OF ACTINOPHAGE-INFECTED CULTURES OF ACT. AUREOFACIENS ON AGARIZED MEDIUM].
    MIKHAILOVA GR
    Antibiotiki; 1964 Mar; 9():217-20. PubMed ID: 14198679
    [No Abstract]   [Full Text] [Related]  

  • 9. ISOLATION AND CHARACTERIZATION OF AN ACTINOPHAGE (PHAGE A) ACTIVE AGAINST A STRAIN OF STREPTOMYCES PRODUCING NOVOBIOCIN.
    HENGELLER C; LICCIARDELLO G; TUDINO V; MARCELLI E; VIRGILIO A
    Nature; 1965 Jan; 205():418-9. PubMed ID: 14243446
    [No Abstract]   [Full Text] [Related]  

  • 10. STUDIES ON THE QUALITY OF NEUTRALIZING BACTERIOPHAGE ANTIBODIES PRODUCED BY SINGLE CELLS. II. EVIDENCE INDICATING THAT DIFFERENT CELLS OF A LYMPH NODE PRODUCE DIFFERENT KINDS OF ANTIBODY AGAINST THE POLYSACCHARIDE ANTIGEN O-9,12 OF SALMONELLA.
    MAEKELAE O
    Immunology; 1964 Jan; 7(1):17-25. PubMed ID: 14113072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUPPRESSION BY ENDOTOXIN OF THE IMMUNE RESPONSE TO ACTINOPHAGE IN THE MOUSE.
    BRADLEY SG; WATSON DW
    Proc Soc Exp Biol Med; 1964 Nov; 117():570-2. PubMed ID: 14233499
    [No Abstract]   [Full Text] [Related]  

  • 12. [USE OF DIMEZOL-14 IN PROTECTING ACT. AUREOFACIENS MYCELIA FROM THE ACTION OF TYPE I ACTINOPHAGE].
    GOLDFARB DM; BORISOVA LN
    Antibiotiki; 1963 Dec; 8():1071-4. PubMed ID: 14172760
    [No Abstract]   [Full Text] [Related]  

  • 13. RIFAMYCIN. XXXIV. PHYSICOCHEMICAL CHARACTERIZATION OF ACTINOPHAGES ACTIVE ON STREPTOMYCES MEDITERRANEI.
    THIEMANN JE; HENGELLER C; VIRGILIO A; BUELLI O; LICCIARDELLO G
    Appl Microbiol; 1964 May; 12(3):269-72. PubMed ID: 14170965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the bacteriophage-neutralizing activity of serums. II. Comparison of normal and immune phage-neutralizing antibodies.
    MUSCHEL LH; TOUSSAINT AJ
    J Immunol; 1962 Jul; 89():35-40. PubMed ID: 14477524
    [No Abstract]   [Full Text] [Related]  

  • 15. ABILITY OF LUPUS ERYTHEMATOSUS SERUM TO INACTIVATE BACTERIOPHAGE PHI-X174 SURVIVING TREATMENT WITH SPECIFIC RABBIT ANTIBODY.
    BOWMAN BU; PATNODE RA
    Proc Soc Exp Biol Med; 1964 Feb; 115():338-41. PubMed ID: 14121604
    [No Abstract]   [Full Text] [Related]  

  • 16. STUDIES ON THE QUALITY OF NEUTRALIZING BACTERIOPHAGE ANTIBODIES PRODUCED BY SINGLE CELLS. II. HETEROGENEITY AMONG ANTI-T2 CELLS AS SHOWN BY DIFFERENT CROSS-REACTIONS.
    MAEKELAE O
    Ann Med Exp Biol Fenn; 1964; 42():152-60. PubMed ID: 14232827
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune response by the mouse to orally administered actinophage.
    BRADLEY SG; KIM YB; WATSON DW
    Proc Soc Exp Biol Med; 1963 Jul; 113():686-8. PubMed ID: 14014837
    [No Abstract]   [Full Text] [Related]  

  • 18. Selection and characteristics of actinophage-resistant variants of Streptomyces erythreus IA 64-575.
    Gurkau M; Ostrowska-Krysiak B
    Acta Microbiol Pol B; 1972; 4(1):23-9. PubMed ID: 5062481
    [No Abstract]   [Full Text] [Related]  

  • 19. PHENOTYPIC MIXING OF BACTERIOPHAGE F2.
    VALENTINE RC; ZINDER ND
    Virology; 1964 Nov; 24():486-7. PubMed ID: 14227053
    [No Abstract]   [Full Text] [Related]  

  • 20. SPECIFIC INHIBITION OF ANTIBODY PRODUCTION. III. APPARENT CHANGES IN THE HALF-LIFE OF BOVINE GAMMA GLOBULIN IN PARALYSED MICE.
    DRESSER DW
    Immunology; 1963 Jul; 6(4):345-55. PubMed ID: 14042901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.